SAN DIEGO, March 1 /PRNewswire-FirstCall/ -- Optimer Pharmaceuticals, Inc. today announced the closing of its previously announced public offering of 4,887,500 shares of its common stock, including 637,500 shares sold pursuant to the full exercise of an over-allotment option previously granted to the underwriter. The net proceeds to Optimer from the sale of shares in the offering, after deducting underwriting discounts and commissions, were approximately $51.5 million.
Jefferies & Company, Inc. acted as sole book-running manager in the offering.
Photo: http://www.newscom.com/cgi-bin/prnh/20090413/LA97352LOGO
AP Archive: http://photoarchive.ap.org
PRN Photo Desk, photodesk@prnewswire.comOptimer Pharmaceuticals, Inc.
